Evidence map›Paper›PMID 30922218›Full record

ArticleBMC genomics2019

Enhanced and controlled chromatin extraction from FFPE tissues and the application to ChIP-seq.

Jian Zhong, Zhenqing Ye, Chad R Clark, Samuel W Lenz, Justin H Nguyen, Huihuang Yan, Keith D Robertson, Gianrico Farrugia, Zhiguo Zhang, Tamas Ordog and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Analysis of DNA Methylation in Gliomas: Assessment of Preanalytical Variables.Laboratory investigation; a journal of technical methods and pathology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Current State of Chromatin Immunoprecipitation (ChIP) from FFPE Tissues.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Jian ZhongEpigenomics Development Laboratory, Epigenomics Program, Center for Individualized Medicine, Mayo Clinic, Stabile building 12-04, 200 First Street SW, Rochester, MN, 55905, USA.
Zhenqing YeDivision of Biomedical Statistics and Informatics, Department of Health Science Research, Mayo Clinic, Rochester, MN, 55905, USA.
Chad R ClarkEpigenomics Development Laboratory, Epigenomics Program, Center for Individualized Medicine, Mayo Clinic, Stabile building 12-04, 200 First Street SW, Rochester, MN, 55905, USA.
Samuel W LenzEpigenomics Development Laboratory, Epigenomics Program, Center for Individualized Medicine, Mayo Clinic, Stabile building 12-04, 200 First Street SW, Rochester, MN, 55905, USA.
Justin H NguyenDepartment of Transplant, Mayo Clinic, Jacksonville, FL, 32224, USA.
Huihuang YanDivision of Biomedical Statistics and Informatics, Department of Health Science Research, Mayo Clinic, Rochester, MN, 55905, USA.
Keith D RobertsonDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, 55905, USA.
Gianrico FarrugiaEnteric Neuroscience Program, Mayo Clinic, Rochester, MN, 55905, USA.
Zhiguo ZhangDepartment of Pediatrics and Department of Genetics and Development, Institute for Cancer Genetics, Columbia University, New York, NY, 10032, USA.
Tamas OrdogEpigenomics Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Jeong-Heon LeeEpigenomics Development Laboratory, Epigenomics Program, Center for Individualized Medicine, Mayo Clinic, Stabile building 12-04, 200 First Street SW, Rochester, MN, 55905, USA. Lee.JeongHeon@mayo.edu.ORCID http://orcid.org/0000-0003-4007-9166
Mayo Clinic · USMayo Clinic in Florida · USCancer Genetics (United States) · US

Funding

Physiological Characterization and Data Integration CoreP01DK068055 · NIDDK · MAYO CLINIC ROCHESTER · PI ORDOG, TAMAS · 2004 to 2019
$23.8M
PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Mechanisms of Epigenetic inheritanceR35GM118015 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Zhiguo Zhang · 2016 to 2026
$9.5M
Interstitial Cells of Cajal in Diabetic GastropathyR01DK058185 · NIDDK · UNIVERSITY OF NEVADA RENO · PI ORDOG, TAMAS · 2002 to 2020
$5.2M
NIDDK NIH HHS P01 DK068055NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK058185NIGMS NIH HHS R35 GM118015NIH HHS P01DK068055
6 · The paper itself

Abstract

backgroundEpigenetic dysregulation is involved in the etiology and progression of various human diseases. Formalin-fixed paraffin-embedded (FFPE) samples represent the gold standard for archiving pathology samples, and thus FFPE samples are a major resource of samples in clinical research. However, chromatin-based epigenetic assays in the clinical settings are limited to fresh or frozen samples, and are hampered by low chromatin yield in FFPE samples due to the lack of a reliable and efficient chromatin preparation method. Here, we introduce a new chromatin extraction method from FFPE tissues (Chrom-EX PE) for chromatin-based epigenetic assays.

resultsDuring rehydration of FFPE tissues, applying a tissue-level cross-link reversal into the deparaffinized tissue at 65 °C dramatically increased chromatin yield in the soluble fraction. The resulting chromatin is compatible with targeted ChIP-qPCR and genome-wide ChIP-seq approaches. The chromatin prepared by Chrom-EX PE showed a gradual fragmentation pattern with varying incubation temperature. At temperatures below 37 °C, the majority of soluble chromatin is over 1 kb. The soluble chromatin prepared in the range of 45-60 °C showed a typical nucleosomal pattern. And the majority of chromatin prepared at 65 °C is close to mononucleosomal size. These observations indicate that chromatin preparation from FFPE samples can be controlled for downstream chromatin-based epigenetic assays.

conclusionsThis study provided a new method that achieves efficient extraction of high-quality chromatin suitable for chromatin-based epigenetic assays with less damage on chromatin. This approach may provide a way to circumvent the over-fixed nature of FFPE tissues for future technology development.

Indexed as

AnimalsChromatinChromatin ImmunoprecipitationEpigenesis, GeneticHigh-Throughput Nucleotide SequencingMiceParaffin EmbeddingReal-Time Polymerase Chain ReactionTemperatureTissue FixationWhole Genome SequencingChromatinChIP-seqChromatin extractionFFPE tissues

Identifiers

PMID30922218
PMCPMC6440302
OpenAlexW2942385366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.